Stay updated on Durvalumab in Resectable Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab in Resectable Lung Cancer Clinical Trial page
- Check7 days agoChange DetectedThe site revision label changed from v3.7.1 to v3.7.2; the study record content remains unchanged.SummaryDifference0.1%

- Check14 days agoChange DetectedThe website footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision marker at the bottom of the page has been updated from v3.6.6 to v3.7.0, reflecting a recent system/UI update to the study history view. This change does not modify any study data or visible content beyond version labeling.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6 on the Record History page, signaling a newer build of the record view.SummaryDifference0.1%

- Check77 days agoChange DetectedThe record history now shows an added revision entry v3.6.5 and the previous revision v3.6.4 was removed. This update reflects changes to the page's version history rather than to trial data or content.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page's revision metadata was updated from v3.6.3 to v3.6.4, indicating a new build of the page and updating the version shown in the history.SummaryDifference0.1%

Stay in the know with updates to Durvalumab in Resectable Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.